Legal Representation
Attorney
Richard D. Allison
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 6, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 6, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 6, 2006 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 6, 2006 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 22, 2006 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 2, 2006 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 2, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 31, 2005 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 31, 2005 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 27, 2005 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 5, 2005 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 15, 2005 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Mar 30, 2005 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Mar 28, 2005 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 20, 2005 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 18, 2005 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Feb 16, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 16, 2005 | I | PAPER RECEIVED | Loading... | |
| Feb 17, 2005 | I | PAPER RECEIVED | Loading... | |
| Aug 16, 2004 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Aug 14, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 31, 2004 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Mar 31, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 31, 2004 | I | PAPER RECEIVED | Loading... | |
| Feb 9, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Vitamin D preparation used for patients with secondary hyperparathyroidism
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005